Research theme for competitive and other funds (4)：
2021 - 2024 TKI治療抵抗性の慢性骨髄性白血病細胞に対する新規治療戦略の開発
2011 - 2015 Analysis of hematopoietic regulation system by circadian rhythm
2011 - 2013 Development of the new treatment strategy of ATRA-resistant APL using PP2A-FOXO3A activation pathway
2005 - 2007 Applications of molecular nanotechnology for human disease using DNA-encode based gene expression analysis
Papers (76)：
Chiho Furuya, Hajime Yasuda, Makoto Hiki, Shuichi Shirane, Tomohito Yamana, Ayana Uchimura, Tadaaki Inano, Tomoiku Takaku, Yasuharu Hamano, Miki Ando. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases. Frontiers in immunology. 2024. 15. 1287300-1287300
Michihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, Naoki Watanabe, Shun Tsuchiya, Tomoiku Takaku, Noriyoshi Iriyama, Eriko Sato, Tomonori Nakazato, Toru Mitsumori, et al. Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. 2023
Koji Tsuchiya, Konobu Kimura, Tomohiko Ai, Takamasa Yamamoto, Kaori Nagasaka, Hiroyuki Takemura, Yoko Edahiro, Kaori Saito, Yuki Horiuchi, Shigeki Misawa, et al. Evaluation of bone marrow aspirates using the automated hematology analyzer Sysmex XN-3000. International journal of laboratory hematology. 2023. 45. 4. 460-468
Tomohiro Kaneko, Sakiko Miyazaki, Azusa Kurita, Ryoko Morimoto, Shun Tsuchiya, Naoki Watanabe, Tomoiku Takaku, Norio Komatsu, Tohru Minamino. Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study. Cardio-oncology (London, England). 2023. 9. 1. 11-11
Shun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, Noriyoshi Iriyama, Yuta Kimura, Eisaku Iwanaga, Kei-ji Sugimoto, Toru Mitsumori, Maho Ishikawa, Tomonori Nakazato, et al. Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice. Internal Medicine. 2023
2024/04 - 現在 Saitama Medical University Division of Hematology Professor
2007/10 - 2010/09 National Insitutes of Health National Heart Lung and Blood institute Post doctal fellow
Committee career (4)：
2023/03 - 現在 Japan Cytometry Society board director
2019/10 - 現在 Japanese Society of Hematology Executive Committee of TFR
2018/10 - 現在 Japanese Society of Hematology Program committee member
2018/09 - 現在 日本血液学会 評議員
Awards (3)：
2012 - National Institutes of Health Orloff Award
2008/06 - Tokyo Medical University Hippocrates
2006 - Tokyo Medical University Sasa Memorial Award
Association Membership(s) (5)：
Japanese Onco-Cadiology Society
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, American Society of Hematology
, JAPAN CYTOMETRY SOCIETY
, THE JAPANESE SOCIETY OF HEMATOLOGY
